Atossa Therapeutics
ATOS
ATOS
67 hedge funds and large institutions have $34.7M invested in Atossa Therapeutics in 2024 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
37% more funds holding
Funds holding: 49 → 67 (+18)
0.17% more ownership
Funds ownership: 0.86% → 1.03% (+0.17%)
Holders
67
Holding in Top 10
–
Calls
$480K
Puts
$195K
Top Buyers
| 1 | +$1.03M | |
| 2 | +$673K | |
| 3 | +$574K | |
| 4 |
HF
HRT Financial
New York
|
+$312K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$266K |
Top Sellers
| 1 | -$395K | |
| 2 | -$360K | |
| 3 | -$137K | |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$75.1K |
| 5 |
BlackRock
New York
|
-$48.4K |